0001413329false00014133292022-12-082022-12-080001413329us-gaap:CommonStockMember2022-12-082022-12-080001413329pm:A2.625Notesdue2023Member2022-12-082022-12-080001413329pm:A2.125Notesdue2023Member2022-12-082022-12-080001413329pm:A3.600Notesdue2023Member2022-12-082022-12-080001413329pm:A2.875Notesdue20241Member2022-12-082022-12-080001413329pm:A2.875Notesdue20242Member2022-12-082022-12-080001413329pm:A0.625Notesdue2024Member2022-12-082022-12-080001413329pm:A3.250Notesdue2024Member2022-12-082022-12-080001413329pm:A2.750Notesdue2025Member2022-12-082022-12-080001413329pm:A3.375Notesdue2025Member2022-12-082022-12-080001413329pm:A2.750Notesdue2026Member2022-12-082022-12-080001413329pm:A2.875Notesdue2026Member2022-12-082022-12-080001413329pm:A0.125Notesdue2026Member2022-12-082022-12-080001413329pm:A3.125Notesdue2027Member2022-12-082022-12-080001413329pm:A3.125Notesdue2028Member2022-12-082022-12-080001413329pm:A2.875Notesdue2029Member2022-12-082022-12-080001413329pm:A3.375Notesdue2029Member2022-12-082022-12-080001413329pm:A0.800Notesdue2031Member2022-12-082022-12-080001413329pm:A3.125Notesdue2033Member2022-12-082022-12-080001413329pm:A2.000Notesdue2036Member2022-12-082022-12-080001413329pm:A1.875Notesdue2037Member2022-12-082022-12-080001413329pm:A6.375Notesdue2038Member2022-12-082022-12-080001413329pm:A1.450Notesdue2039Member2022-12-082022-12-080001413329pm:A4.375Notesdue2041Member2022-12-082022-12-080001413329pm:A4.500Notesdue2042Member2022-12-082022-12-080001413329pm:A3.875Notesdue2042Member2022-12-082022-12-080001413329pm:A4.125Notesdue2043Member2022-12-082022-12-080001413329pm:A4.875Notesdue2043Member2022-12-082022-12-080001413329pm:A4.250Notesdue2044Member2022-12-082022-12-08

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549



FORM 8-K



CURRENT REPORT
Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): December 8, 2022



Philip Morris International Inc.
(Exact name of registrant as specified in its charter)

Virginia
1-33708
13-3435103
(State or other jurisdiction
of incorporation)
(Commission File Number)
(I.R.S. Employer
Identification No.)

677 Washington Blvd, Ste. 1100StamfordConnecticut06901
(Address of principal executive offices)(Zip Code)


Registrant's telephone number, including area code: (203) 905-2410
(Former name or former address, if changed since last report.)



Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:




Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))




Securities registered pursuant to Section 12(b) of the Act:

Title of each classTrading Symbol(s)Name of each exchange on which registered
Common Stock, no par valuePMNew York Stock Exchange
2.625% Notes due 2023PM23New York Stock Exchange
2.125% Notes due 2023PM23BNew York Stock Exchange
3.600% Notes due 2023PM23ANew York Stock Exchange
2.875% Notes due 2024PM24New York Stock Exchange
2.875% Notes due 2024PM24CNew York Stock Exchange
0.625% Notes due 2024PM24BNew York Stock Exchange
3.250% Notes due 2024PM24ANew York Stock Exchange
2.750% Notes due 2025PM25New York Stock Exchange
3.375% Notes due 2025PM25ANew York Stock Exchange
2.750% Notes due 2026PM26ANew York Stock Exchange
2.875% Notes due 2026PM26New York Stock Exchange
0.125% Notes due 2026PM26BNew York Stock Exchange
3.125% Notes due 2027PM27New York Stock Exchange
3.125% Notes due 2028PM28New York Stock Exchange
2.875% Notes due 2029PM29New York Stock Exchange
3.375% Notes due 2029PM29ANew York Stock Exchange
0.800% Notes due 2031PM31New York Stock Exchange
3.125% Notes due 2033PM33New York Stock Exchange
2.000% Notes due 2036PM36New York Stock Exchange
1.875% Notes due 2037PM37ANew York Stock Exchange
6.375% Notes due 2038PM38New York Stock Exchange
1.450% Notes due 2039PM39New York Stock Exchange
4.375% Notes due 2041PM41New York Stock Exchange
4.500% Notes due 2042PM42New York Stock Exchange
3.875% Notes due 2042PM42ANew York Stock Exchange
4.125% Notes due 2043PM43New York Stock Exchange
4.875% Notes due 2043PM43ANew York Stock Exchange
4.250% Notes due 2044PM44New York Stock Exchange




Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
                                                
         Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.




Item 5.02.
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

Appointment of Certain Officers

On December 8, 2022, the Board of Directors (the “Board”) of Philip Morris International Inc. (the “Company”) approved the appointment of Jorge Insuasty as the full-time President, Vectura Fertin Pharma, effective January 1, 2023. In connection with this appointment, Mr. Insuasty will no longer also serve as Chief Life Sciences Officer of the Company and Badrul Chowdhury, the Company’s Chief Life Sciences Officer, Smoke-Free Products, will report directly to the Company’s Chief Executive Officer, Jacek Olczak.

Mr. Insuasty will continue to report directly to Mr. Olczak, and no changes were made to Mr. Insuasty’s compensation arrangements in connection with the change in his role.

Compensatory Arrangements of Certain Officers

As part of the Company’s regional restructuring and as previously disclosed in the Company’s Current Report on Form 8-K filed on November 25, 2022, Frederic de Wilde, currently President, European Union Region, will be appointed President, South and Southeast Asia (SSEA), Commonwealth of Independent States (CIS), Middle East and Africa (MEA) Region. In connection with the foregoing, on December 8, 2022, the Board approved the following changes to Mr. de Wilde’s compensation, to be effective on his appointment:

Mr. de Wilde will be promoted to salary grade 26 and his base salary will be increased to CHF 1,000,008 (approximately $1,080,009 at the current exchange rate). Mr. de Wilde’s annual incentive compensation award target will be at 125% of his new base salary and his equity award target will be at 275% of his new base salary. The Company will provide additional information regarding the compensation of its named executive officers in the Company’s proxy statement for the 2023 Annual Shareholders Meeting.






























SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

PHILIP MORRIS INTERNATIONAL INC.
By:/s/ DARLENE QUASHIE HENRY
Name:Darlene Quashie Henry
Title:Vice President, Associate General Counsel & Corporate Secretary
Date: December 14, 2022



Philip Morris (NYSE:PM)
Historical Stock Chart
Von Feb 2024 bis Mär 2024 Click Here for more Philip Morris Charts.
Philip Morris (NYSE:PM)
Historical Stock Chart
Von Mär 2023 bis Mär 2024 Click Here for more Philip Morris Charts.